SPP1 and metabolic dysfunction-associated steatotic liver disease: As SPP1 is involved in fibrosis regulation and triggers the release of multiple inflammatory cytokines, its activity is increased in NAFLD and paralleled with fibrosis stages, and SPP1 neutralization might be useful for preventing progressive hepatic fibrosis in NASH patients (17).